CN Stock MarketDetailed Quotes

300765 CSPC Innovation Pharmaceutical

Watchlist
  • 38.35
  • -1.92-4.77%
Trading May 7 14:42 CST
53.87BMarket Cap-1036.49P/E (TTM)

CSPC Innovation Pharmaceutical Key Stats

CSPC Innovation Pharmaceutical Q1 2025 Earnings Date

Currency:CNYApr 24, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
--
471.97M
--
-9.94%
EPS
--
-0.02
--
-128.40%
Strong Buy

May 7, 2025

CSPC Innovation Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2026/FY-- / 5.163B--
--2025/FY-- / 3.535B--
Mar 21, 20252024/FY1.981B / 2.432B--
Mar 15, 20242023/FY2.502B / 2.708B--
Mar 17, 20232022/FY2.626B / 1.958B--
DatePeriodRevenue/EstimateEarnings Call
--2026/FY-- / 5.163B--
--2025/FY-- / 3.535B--
Mar 21, 20252024/FY1.981B / 2.432B--
Mar 15, 20242023/FY2.502B / 2.708B--
Mar 17, 20232022/FY2.626B / 1.958B--

Unlock Free Earnings Estimates

CSPC Innovation Pharmaceutical Earnings Reports

Read more

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve Show More